MAPT and Alzheimer disease: Our findings are incompatible with (1) the hypothesis that the presence of Aβ deposits is mandatory for the development of abnormal tau inclusions and neuronal loss in AD as well as (2) the concept that distinct neuropathological criteria should be applied to definite PART and AD.